CD38 and acute myeloid leukemia: Using fluorescently labeled recombinant human E-selectin–IgM fusion protein6, we found that healthy human CD34+ CD38− HSC display a range of E-selectin binding potentials, whereas primary AML CD34+ CD38− blasts bind strongly (Fig. 2a).